{
  "trial_id": "NCT03215914",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "subject be enrolled. Repeated clinical testing throughout the study will ensure the continued safety and minimization of risk for the enrolled participants.",
      "label": "met"
    },
    {
      "criterion": "Study Intervention Phase Eligible subjects will complete a baseline assessment of glucose counterregulation by stepped-hyperinsulinemic hypoglycemic clamp prior to starting intervention with the hybrid closed-loop system (MiniMed 670G system, Medtronic Diabetes, Northridge, CA).",
      "label": "met"
    },
    {
      "criterion": "Male and female subjects age 25 to 70 years.",
      "label": "met"
    },
    {
      "criterion": "Subjects who are able to provide written informed consent and to comply with the procedures of the study protocol.",
      "label": "met"
    },
    {
      "criterion": "Clinical history compatible with type 1 diabetes with disease onset < 40 years of age and insulin dependent for > 10 years.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "BMI \u2265 30 kg/m2.",
      "label": "not_met"
    },
    {
      "criterion": "Insulin requirement of \u2265 1.0 units/kg\u2022day.",
      "label": "unknown"
    }
  ],
  "notes": "The patient has type 1 diabetes confirmed with molecular analysis 7 years ago and is diagnosed with cardiomyopathy that will be treated with ACE inhibitors and Beta blockers.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT03215914",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}